BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 6111161)

  • 1. [Effects of nitroglycerin on exercise hemodynamics in patients with coronary heart disease under treatment with beta-blockers (mepindolol, oxprenolol) and a calcium-antagonist (fendiline) (author's transl)].
    Reiterer W
    Wien Med Wochenschr; 1980 Dec; 130(23):772-7. PubMed ID: 6111161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anti-ischemic action of the transdermally applied beta-receptor blocker, mepindolol in patients with stable angina pectoris].
    Bonelli J; Gazo F; Liedtke RK
    Arzneimittelforschung; 1989 Nov; 39(11A):1515-7. PubMed ID: 2576203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anti-ischemic action of the transdermally-applied beta-receptor blocker, mepindolol, in patients with stable angina pectoris. Comparison with transdermal nitrate].
    Bonelli J; Gazo F; Falkner C; Liedtke RK
    Arzneimittelforschung; 1990 Aug; 40(8):876-9. PubMed ID: 1978680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of calcium antagonists in therapy of coronary heart disease. Experimental report on the calcium antagonist fendiline, and the beta receptor blockader metoprolol].
    Ardjah H
    Med Welt; 1980 Sep; 31(37):1326-30. PubMed ID: 7432128
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of Sensit on central hemodynamics in patients with ischemic heart disease].
    Kliuka GR; Sinitsa KI; Okhon'ko VI; Sinitsa TN; Pilipchuk LR
    Vrach Delo; 1987 Nov; (11):19-20. PubMed ID: 3439113
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute influence of different beta-blocking agents upon left heart hemodynamics at rest and during exercise in patients with coronary artery disease.
    Reale A; Nigri A; Gioffrè PA; Motolese M
    Eur J Cardiol; 1979 Feb; 9(2):101-9. PubMed ID: 32041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hemodynamics in patients with coronary heart disease under conditions of physical exercise before and after mepindolol-sulfate (author's transl)].
    Bonelli J; Magometschnigg D; Hitzenberger G; Kaik G
    Z Kardiol; 1978 Jan; 67(1):51-6. PubMed ID: 343414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The treatment of acute myocardial infarctions with beta-receptor-blockers. II. Hemodynamic effects of propranolol with and without combination therapy with nitroglycerin (author's transl)].
    Lehmann HU; Oeff M; Witt E; Hochrein H
    Z Kardiol; 1981 Oct; 70(10):748-53. PubMed ID: 6795841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hemodynamic differences in the effects of mepindolol-sulfate and propranolol after 4 weeks treatment under conditions of rest and physical exercise in patients with coronary heart disease (author's transl)].
    Bonelli J; Magometschnigg D; Hitzenberger G; Kaik G
    Z Kardiol; 1978 Jan; 67(1):46-50. PubMed ID: 629073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A double blind cross-over study with mepindolol-sulfate in patients with coronary heart disease (author's transl)].
    Bonelli J; Magometschnigg D; Schober H; Kleinberger G; Pichler H; Kaik G
    Wien Med Wochenschr; 1979 Oct; 129(19):541-6. PubMed ID: 42224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fendiline hydrochloride as a therapeutic agent in chronic coronary insufficiency].
    Vichi FL
    Arq Bras Cardiol; 1980 Apr; 34(4):327-30. PubMed ID: 7002122
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of patients with ischemic heart diseases using senzit].
    Zamotaev IP; Venediktova MG; Zakharova GIu
    Klin Med (Mosk); 1988 Aug; 66(8):68-71. PubMed ID: 3193737
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of Fendilin on the exercise test in patients with coronary disease].
    Spiel R; Enenkel W
    Wien Med Wochenschr; 1976 Mar; 126(13-14):186-9. PubMed ID: 10680
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of sensit on the course of ischemic heart disease].
    Nesvetov VN; Gorshkov VA; Kuliamin VI; Buskin VD
    Sov Med; 1988; (3):57-61. PubMed ID: 3413552
    [No Abstract]   [Full Text] [Related]  

  • 15. [Fendiline (Sensit) in the treatment of coronary disease].
    Bała T; Gajewska B; Adamska-Dyniewska H
    Wiad Lek; 1983 Apr; 36(7):525-30. PubMed ID: 6349131
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of hypertension with a combination of pyridopyridazine derivative with a beta-receptor blocker. Studies on the hemodynamic course (author's transl)].
    Lehmann HU; Witt E; Hochrein H
    MMW Munch Med Wochenschr; 1978 Jun; 120(23):803-6. PubMed ID: 26870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fendiline for hypodynamic coronary heart disease patients. Calmodulin antagonists--alternatives to calcium antagonism].
    Fortschr Med; 1985 Oct; 103(40):64. PubMed ID: 4065792
    [No Abstract]   [Full Text] [Related]  

  • 18. [Fendiline brings oxygen to the myocardium].
    von Bock und Polach U
    Med Klin; 1981 Sep; 76(19):541-4. PubMed ID: 7024764
    [No Abstract]   [Full Text] [Related]  

  • 19. [Influence of digitalis on pindolol activity in exercise-induced cardiac failure in patients with coronary disease (author's transl)].
    Oeff M; Beck OA; Hochrein H
    Dtsch Med Wochenschr; 1979 Jan; 104(3):98-103. PubMed ID: 759158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemodynamic and humoral effects of fendiline, a calcium antagonist drug, in idiopathic hypertension patients].
    Castellano M; Beschi M; Muiesan ML; Romanelli G; Muiesan G
    Cardiologia; 1984; 29(7-8):359-66. PubMed ID: 6542415
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.